author-photo

Maria Luisa T. Abesamis-Tiambeng

5

Papers

101

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Biosimilar trastuzumab-dkst monotherapy versus trastuzumab monotherapy after combination therapy: Toxicity, efficacy, and immunogenicity from the phase 3 Heritage trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)